Dachshund Binds P53 to Block the Growth of Lung Adenocarcinoma Cells

Ke Chen,Kongming Wu,Shaoxin Cai,Wei Zhang,Jie Zhou,Jing Wang,Adam Ertel,Zhiping Li,Hallgeir Rui,Andrew Quong,Michael P. Lisanti,Aydin Tozeren,Ceylan Tanes,Sankar Addya,Michael Gormley,Chenguang Wang,Steven B. McMahon,Richard G. Pestell

DOI: https://doi.org/10.1158/0008-5472.can-12-3191

IF: 11.2

2013-01-01

Cancer Research

Abstract:Abstract Hyperactive EGF receptor (EGFR) and mutant p53 are common genetic abnormalities driving the progression of non–small cell lung cancer (NSCLC), the leading cause of cancer deaths in the world. The Drosophila gene Dachshund (Dac) was originally cloned as an inhibitor of hyperactive EGFR alleles. Given the importance of EGFR signaling in lung cancer etiology, we examined the role of DACH1 expression in lung cancer development. DACH1 protein and mRNA expression was reduced in human NSCLC. Reexpression of DACH1 reduced NSCLC colony formation and tumor growth in vivo via p53. Endogenous DACH1 colocalized with p53 in a nuclear, extranucleolar location, and shared occupancy of −15% of p53-bound genes in ChIP sequencing. The C-terminus of DACH1 was necessary for direct p53 binding, contributing to the inhibition of colony formation and cell-cycle arrest. Expression of the stem cell factor SOX2 was repressed by DACH1, and SOX2 expression was inversely correlated with DACH1 in NSCLC. We conclude that DACH1 binds p53 to inhibit NSCLC cellular growth. Cancer Res; 73(11); 3262–74. ©2013 AACR.